Drug delivery systems for metabolic disorders:
Drug Delivery Systems for Metabolic Disorders presents the most recent developments on the targeted delivery of drugs to deal with metabolic disorders in a safe, compliant and continuous way. The book covers recent developments in advanced drug delivery systems in various metabolic disorders, includ...
Gespeichert in:
Weitere Verfasser: | , , , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
London ; San Diego, CA ; Cambridge, MA ; Kidlington
Academic Press, an imprint of Elsevier
[2022]
|
Schlagworte: | |
Zusammenfassung: | Drug Delivery Systems for Metabolic Disorders presents the most recent developments on the targeted delivery of drugs to deal with metabolic disorders in a safe, compliant and continuous way. The book covers recent developments in advanced drug delivery systems in various metabolic disorders, including disturbances in protein, lipid, carbohydrate and hormone metabolism and lysosomal and mitochondrial disorders. It provides a brief introduction to metabolic disorders, along with a focus on the current landscape and trends in understanding disease pathology using different in vitro and in vivo models required for clinical applications and developments of new therapeutics.Each subsequent chapter covers drug delivery systems dedicated to metabolic diseases caused by disturbances in protein, lipid, carbohydrate and hormone metabolism. Then, it moves on to cover lysosomal storage disorders and applications of phytopharmaceuticals in this context. This is the perfect reference for researchers in pharmaceutical science who are interested in developing new treatments for metabolic diseases |
Beschreibung: | xx, 505 Seiten Illustrationen, Diagramme |
ISBN: | 9780323996167 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV048504725 | ||
003 | DE-604 | ||
005 | 20221114 | ||
007 | t | ||
008 | 221010s2022 a||| |||| 00||| eng d | ||
020 | |a 9780323996167 |c paperback |9 978-0-323-99616-7 | ||
035 | |a (OCoLC)1350781364 | ||
035 | |a (DE-599)BVBBV048504725 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-29 | ||
245 | 1 | 0 | |a Drug delivery systems for metabolic disorders |c edited by Harish Dureja, S. Narasimha Murthy, Peter R. Wich, Kamal Dua |
264 | 1 | |a London ; San Diego, CA ; Cambridge, MA ; Kidlington |b Academic Press, an imprint of Elsevier |c [2022] | |
264 | 4 | |c © 2022 | |
300 | |a xx, 505 Seiten |b Illustrationen, Diagramme | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
520 | |a Drug Delivery Systems for Metabolic Disorders presents the most recent developments on the targeted delivery of drugs to deal with metabolic disorders in a safe, compliant and continuous way. The book covers recent developments in advanced drug delivery systems in various metabolic disorders, including disturbances in protein, lipid, carbohydrate and hormone metabolism and lysosomal and mitochondrial disorders. It provides a brief introduction to metabolic disorders, along with a focus on the current landscape and trends in understanding disease pathology using different in vitro and in vivo models required for clinical applications and developments of new therapeutics.Each subsequent chapter covers drug delivery systems dedicated to metabolic diseases caused by disturbances in protein, lipid, carbohydrate and hormone metabolism. Then, it moves on to cover lysosomal storage disorders and applications of phytopharmaceuticals in this context. This is the perfect reference for researchers in pharmaceutical science who are interested in developing new treatments for metabolic diseases | ||
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
700 | 1 | |a Dureja, Harish |4 edt | |
700 | 1 | |a Murthy, S. Narasimha |4 edt | |
700 | 1 | |a Wich, Peter R. |0 (DE-588)13923988X |4 edt | |
700 | 1 | |a Dua, Kamal |0 (DE-588)1219938602 |4 edt | |
999 | |a oai:aleph.bib-bvb.de:BVB01-033881908 |
Datensatz im Suchindex
_version_ | 1804184476534702080 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author2 | Dureja, Harish Murthy, S. Narasimha Wich, Peter R. Dua, Kamal |
author2_role | edt edt edt edt |
author2_variant | h d hd s n m sn snm p r w pr prw k d kd |
author_GND | (DE-588)13923988X (DE-588)1219938602 |
author_facet | Dureja, Harish Murthy, S. Narasimha Wich, Peter R. Dua, Kamal |
building | Verbundindex |
bvnumber | BV048504725 |
ctrlnum | (OCoLC)1350781364 (DE-599)BVBBV048504725 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02212nam a2200325 c 4500</leader><controlfield tag="001">BV048504725</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20221114 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">221010s2022 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780323996167</subfield><subfield code="c">paperback</subfield><subfield code="9">978-0-323-99616-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1350781364</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048504725</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug delivery systems for metabolic disorders</subfield><subfield code="c">edited by Harish Dureja, S. Narasimha Murthy, Peter R. Wich, Kamal Dua</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London ; San Diego, CA ; Cambridge, MA ; Kidlington</subfield><subfield code="b">Academic Press, an imprint of Elsevier</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xx, 505 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Drug Delivery Systems for Metabolic Disorders presents the most recent developments on the targeted delivery of drugs to deal with metabolic disorders in a safe, compliant and continuous way. The book covers recent developments in advanced drug delivery systems in various metabolic disorders, including disturbances in protein, lipid, carbohydrate and hormone metabolism and lysosomal and mitochondrial disorders. It provides a brief introduction to metabolic disorders, along with a focus on the current landscape and trends in understanding disease pathology using different in vitro and in vivo models required for clinical applications and developments of new therapeutics.Each subsequent chapter covers drug delivery systems dedicated to metabolic diseases caused by disturbances in protein, lipid, carbohydrate and hormone metabolism. Then, it moves on to cover lysosomal storage disorders and applications of phytopharmaceuticals in this context. This is the perfect reference for researchers in pharmaceutical science who are interested in developing new treatments for metabolic diseases</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dureja, Harish</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Murthy, S. Narasimha</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wich, Peter R.</subfield><subfield code="0">(DE-588)13923988X</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dua, Kamal</subfield><subfield code="0">(DE-588)1219938602</subfield><subfield code="4">edt</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033881908</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV048504725 |
illustrated | Illustrated |
index_date | 2024-07-03T20:45:38Z |
indexdate | 2024-07-10T09:39:57Z |
institution | BVB |
isbn | 9780323996167 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033881908 |
oclc_num | 1350781364 |
open_access_boolean | |
owner | DE-29 |
owner_facet | DE-29 |
physical | xx, 505 Seiten Illustrationen, Diagramme |
publishDate | 2022 |
publishDateSearch | 2022 |
publishDateSort | 2022 |
publisher | Academic Press, an imprint of Elsevier |
record_format | marc |
spelling | Drug delivery systems for metabolic disorders edited by Harish Dureja, S. Narasimha Murthy, Peter R. Wich, Kamal Dua London ; San Diego, CA ; Cambridge, MA ; Kidlington Academic Press, an imprint of Elsevier [2022] © 2022 xx, 505 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Drug Delivery Systems for Metabolic Disorders presents the most recent developments on the targeted delivery of drugs to deal with metabolic disorders in a safe, compliant and continuous way. The book covers recent developments in advanced drug delivery systems in various metabolic disorders, including disturbances in protein, lipid, carbohydrate and hormone metabolism and lysosomal and mitochondrial disorders. It provides a brief introduction to metabolic disorders, along with a focus on the current landscape and trends in understanding disease pathology using different in vitro and in vivo models required for clinical applications and developments of new therapeutics.Each subsequent chapter covers drug delivery systems dedicated to metabolic diseases caused by disturbances in protein, lipid, carbohydrate and hormone metabolism. Then, it moves on to cover lysosomal storage disorders and applications of phytopharmaceuticals in this context. This is the perfect reference for researchers in pharmaceutical science who are interested in developing new treatments for metabolic diseases (DE-588)4143413-4 Aufsatzsammlung gnd-content Dureja, Harish edt Murthy, S. Narasimha edt Wich, Peter R. (DE-588)13923988X edt Dua, Kamal (DE-588)1219938602 edt |
spellingShingle | Drug delivery systems for metabolic disorders |
subject_GND | (DE-588)4143413-4 |
title | Drug delivery systems for metabolic disorders |
title_auth | Drug delivery systems for metabolic disorders |
title_exact_search | Drug delivery systems for metabolic disorders |
title_exact_search_txtP | Drug delivery systems for metabolic disorders |
title_full | Drug delivery systems for metabolic disorders edited by Harish Dureja, S. Narasimha Murthy, Peter R. Wich, Kamal Dua |
title_fullStr | Drug delivery systems for metabolic disorders edited by Harish Dureja, S. Narasimha Murthy, Peter R. Wich, Kamal Dua |
title_full_unstemmed | Drug delivery systems for metabolic disorders edited by Harish Dureja, S. Narasimha Murthy, Peter R. Wich, Kamal Dua |
title_short | Drug delivery systems for metabolic disorders |
title_sort | drug delivery systems for metabolic disorders |
topic_facet | Aufsatzsammlung |
work_keys_str_mv | AT durejaharish drugdeliverysystemsformetabolicdisorders AT murthysnarasimha drugdeliverysystemsformetabolicdisorders AT wichpeterr drugdeliverysystemsformetabolicdisorders AT duakamal drugdeliverysystemsformetabolicdisorders |